Comparing efficacy and safety of P013, a proposed pertuzumab biosimilar, with the reference product in HER2-positive breast cancer patients: a randomized …
.png)
All site rights belong to Radiology Research Center
پورتال سازمانيChange font color:
Main Color:
Secondary Color:
Change Background Color:
Change word space:
Change line space:
Change mouse pointer:
Change font
By selecting the color blind mode, the images of this website will be optimized according to your color blind mode
comment